Taken together, the larger effect size between COVID-19 and healthy controls as well as the higher expression levels in monocytes suggested that IFI27 and SIGLEC1 is a monocyte-specific biomarker with slightly different property in response to viral infection. The gene discussed is SIGLEC1; the disease is viral infectious disease.